Genovis

• The Balance Sheet and Income Statement as well as the Consolidated Income Statement and the Consolidated Balance Sheet were adopted.

• The Board and the Chief Executive Officer were discharged from liability.

• The Board shall consist until the next AGM of five ordinary members without deputies.

• Re-election of Board members Torben Jørgensen, Mikael Lönn, Lotta Ljungqvist, Steve Jordan and Magnus Gustafsson.

Torben Jørgensen was elected Chairperson of the Board.

• Remuneration will be paid to the Board of Directors in the amount of SEK 220,000 to Board members and SEK 500,000 to the Chairperson of the Board. 

• Remuneration to the auditors will be paid on approved account.  

• In accordance with the Nomination Committee's proposal, the Meeting re-elected the accounting firm Öhrlings PricewaterhouseCoopers AB as auditor for the period until the close of the Annual General Meeting 2025.

• A Nomination Committee will be formed with representatives of the four largest shareholders on September 30, 2024.

• The AGM resolved on the authorization to issue shares with or without preferential rights for existing shareholders. As a result of this resolution, share capital could increase by a maximum of SEK 1,625,000 through the issuance of a maximum of 6,500,000 shares.

Minutes with all resolutions from the meeting will be made available on the company's website:

https://investor.genovis.com/en/corporate-governance/general-meeting/